Karen Rascati, PhD, Professor Landon Marshall, PharmD, PhD student Transforming Pediatric Healthcare Delivery: Analysis of Texas Medicaid Claims Data to Support an Ongoing Randomized Controlled Trial Karen Rascati, PhD, Professor Landon Marshall, PharmD, PhD student UT College of Pharmacy

Figure 1 Figure 2 Figure 3 Figure 4

What are their implications for policy and practice? Although medication costs are higher in the experimental group – overall costs are not that different This may be due to additions to treatment (adding needed medications) as well as better adherence to prescribed medications.

Where is this area of research/ collaboration headed from here? Next step is to look at the most common/costly outpatient services and see if these change over time for the experimental group vs. the control group.